Market Indices
Latest News
 |
Bassett Furniture Industries, Incorporated (BSET) confirmed earnings release on April 01,...
March 31, 2026 BSET -0.21% |
| ||
| ||
| ||
|
Price Targets
Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...
March 18, 2026 CTMX 5.10%
Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,
March 17, 2026 ABEO 5.32%
Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,
March 17, 2026 CTRN 3.78%
Greg Renza from Truist Financial issued a price target of $12.00 for CATX on 2026-03-17 12:35:00.The adjusted price target was set to $12.00.At the time of the announcement,
March 17, 2026 CATX 7.18%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| TMCWW TMC the metals company In | 0.36
32.20% | ||||||||||||||||||
| CTXR Citius Pharmaceuticals, I | 0.89
30.70% | ||||||||||||||||||
| DWSN Dawson Geophysical Compan | 3.33
26.14% | ||||||||||||||||||
| KSCP Knightscope, Inc. | 4.23
24.45% | ||||||||||||||||||
| CGTX Cognition Therapeutics, I | 0.73
22.77% | ||||||||||||||||||
| MIST Milestone Pharmaceuticals | 1.24
22.28% | ||||||||||||||||||
| PGEN Precigen, Inc. | 3.86
18.77% | ||||||||||||||||||
| AIXI Xiao-I Corporation | 0.12
18.73% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 9.10%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 10.24%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 3.18%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.05%